Innate and acquired immunity in atherogenesis (Q34986341)

5 August 2017

1 reference

title

Innate and acquired immunity in atherogenesis (English)

1 reference

5 August 2017

7

Joseph L Witztum

1 reference

5 August 2017

Christoph J Binder

1

1 reference

5 August 2017

Mi-Kyung Chang

2

1 reference

5 August 2017

Peter X Shaw

3

1 reference

5 August 2017

Yury I Miller

4

1 reference

5 August 2017

Karsten Hartvigsen

5

1 reference

5 August 2017

Asheesh Dewan

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

8

1 reference

5 August 2017

1218-1226

1 reference

5 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1102-1218

5 August 2017

0 references

cites work

High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Common low-density lipoprotein receptor mutations in the French Canadian population

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Atherosclerosis. the road ahead

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Immune mechanisms in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Immunological responses to oxidized LDL.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

The response-to-retention hypothesis of atherogenesis reinforced

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Lipid peroxidation in mouse models of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Evidence for a role of phospholipid oxidation products in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Oxidized LDL contains inflammatory PAF-like phospholipids

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Lymphocytes are important in early atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Decoding the patterns of self and nonself by the innate immune system

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Toll-like receptors and innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Oxidized phospholipids and isoprostanes in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Infectious agents are not necessary for murine atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Toll-like Receptor 4 Polymorphisms and Atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

The macrophage foam cell as a target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Influence of C3 deficiency on atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Human C-reactive protein: expression, structure, and function

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Generation of C-reactive protein and complement components in atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

The vascular-associated lymphoid tissue: a new site of local immunity

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst(beige) mutations

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Requirement for CD154 in the progression of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Splenectomy and subsequent mortality in veterans of the 1939-45 war.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Dental infections and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Atherosclerosis as an autoimmune disease: an update

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1218

7 January 2021

Identifiers

DOI

10.1038/NM1102-1218

1 reference

5 August 2017

1 reference